BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Effendi WI, Nagano T. Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge. IJMS 2022;23:6064. [DOI: 10.3390/ijms23116064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kadefors M, Berlin F, Wildt M, Dellgren G, Rolandsson Enes S, Aspberg A, Westergren-thorsson G. Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis. Front Pharmacol 2022;13:953771. [DOI: 10.3389/fphar.2022.953771] [Reference Citation Analysis]
2 Tieyuan Z, Ying Z, Xinghua Z, Huimin W, Huagang L. Piceatannol-mediated JAK2/STAT3 signaling pathway inhibition contributes to the alleviation of oxidative injury and collagen synthesis during pulmonary fibrosis. Int Immunopharmacol 2022;111:109107. [PMID: 35932616 DOI: 10.1016/j.intimp.2022.109107] [Reference Citation Analysis]